NO20090745L - Varmebehandlete bakteriner, og emulsjonsvaksiner fremstilt av slike varmebehandlete bakteriner - Google Patents

Varmebehandlete bakteriner, og emulsjonsvaksiner fremstilt av slike varmebehandlete bakteriner

Info

Publication number
NO20090745L
NO20090745L NO20090745A NO20090745A NO20090745L NO 20090745 L NO20090745 L NO 20090745L NO 20090745 A NO20090745 A NO 20090745A NO 20090745 A NO20090745 A NO 20090745A NO 20090745 L NO20090745 L NO 20090745L
Authority
NO
Norway
Prior art keywords
heat
treated bacteria
vaccines produced
emulsion vaccines
bacteria
Prior art date
Application number
NO20090745A
Other languages
English (en)
Other versions
NO339147B1 (no
Inventor
Mark Davis Goodyear
Michael John Huether
Ramasamy Mannar Mannan
Nancee Lois Oien
Original Assignee
Zoetis P Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis P Llc filed Critical Zoetis P Llc
Publication of NO20090745L publication Critical patent/NO20090745L/no
Publication of NO339147B1 publication Critical patent/NO339147B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Sammendrag Det beskrives varmebehandlete bakteriner, en fremgangsmåte for å produsere varmebehandlete bakteriner, og emulsjonsvaksiner fremstilt fra slike varmebehandlete bakteriner.
NO20090745A 2006-09-11 2009-02-16 Varmebehandlete bakteriner, og emulsjonsvaksiner fremstilt av slike varmebehandlete bakteriner NO339147B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84366506P 2006-09-11 2006-09-11
PCT/IB2007/002553 WO2008032158A2 (en) 2006-09-11 2007-08-30 Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins

Publications (2)

Publication Number Publication Date
NO20090745L true NO20090745L (no) 2009-03-11
NO339147B1 NO339147B1 (no) 2016-11-14

Family

ID=39110574

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090745A NO339147B1 (no) 2006-09-11 2009-02-16 Varmebehandlete bakteriner, og emulsjonsvaksiner fremstilt av slike varmebehandlete bakteriner

Country Status (27)

Country Link
US (1) US8491915B2 (no)
EP (2) EP2377550B1 (no)
JP (2) JP5550341B2 (no)
KR (1) KR101238486B1 (no)
CN (1) CN101516393B (no)
AR (1) AR062758A1 (no)
AU (1) AU2007297287B2 (no)
BR (1) BRPI0716548B1 (no)
CA (1) CA2663166C (no)
CL (1) CL2007002621A1 (no)
CO (1) CO6160333A2 (no)
DK (2) DK2066340T3 (no)
ES (2) ES2432392T3 (no)
HK (1) HK1130202A1 (no)
ME (1) ME00598B (no)
MX (1) MX2009001849A (no)
NO (1) NO339147B1 (no)
NZ (2) NZ574896A (no)
PL (2) PL2377550T3 (no)
PT (1) PT2066340E (no)
RS (1) RS54981B1 (no)
RU (2) RU2425692C2 (no)
SI (1) SI2066340T1 (no)
TW (1) TWI361077B (no)
UA (1) UA98115C2 (no)
WO (1) WO2008032158A2 (no)
ZA (1) ZA200902493B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009090461A1 (en) * 2007-12-21 2009-07-23 Pfizer Inc. Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins
EP2717055A1 (en) * 2012-10-04 2014-04-09 Institut Pasteur Use of Leptospira fainei serovar Hurstbridge bacteria for diagnosing leptospirosis
JP2024510057A (ja) * 2020-05-26 2024-03-06 サイラス トェンティファースト センチュリー アントレプレナーシップ エルエルシー ハキムプールシナの除染手順

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3721169A1 (de) * 1986-06-30 1988-01-14 Lion Corp Orale zubereitung
US5084269A (en) 1986-11-06 1992-01-28 Kullenberg Fred W Adjuvant for dose treatment with antigens
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
AU2001234616A1 (en) 2000-01-31 2001-08-07 Vic Jira Vaccine composition, process and methods
US20030147914A1 (en) 2001-07-02 2003-08-07 Pfizer Inc. Mycoplasma bovis vaccine and methods of reducing pneumonia in animals
CA2496750C (en) 2002-08-26 2014-10-21 Pfizer Products Inc. Vaccine for respiratory and reproductive system infections in cattle
EP1549135A4 (en) 2002-09-20 2006-01-11 Us Agriculture VACCINE AND ADJUVANT COMPOSITIONS
AU2002951692A0 (en) 2002-09-23 2002-10-17 Vital Biotech (Hong Kong) Limited Improvements in or relating to vaccines
KR20050103215A (ko) * 2003-01-29 2005-10-27 화이자 프로덕츠 인코포레이티드 보르데텔라 브론키셉티카에 대한 개 백신
PT1613346E (pt) * 2003-04-04 2013-01-29 Pah Usa 15 Llc Emulsões óleo-em-água microfluidificadas e composições de vacinas

Also Published As

Publication number Publication date
MEP7509A (en) 2011-12-20
US20080112970A1 (en) 2008-05-15
DK2377550T3 (en) 2015-04-07
NZ595748A (en) 2013-07-26
RS54981B1 (sr) 2016-11-30
KR101238486B1 (ko) 2013-03-04
JP2014088428A (ja) 2014-05-15
RU2569457C2 (ru) 2015-11-27
RU2009108004A (ru) 2010-10-20
AU2007297287B2 (en) 2013-03-14
CO6160333A2 (es) 2010-05-20
ES2432392T3 (es) 2013-12-03
ES2535977T3 (es) 2015-05-19
WO2008032158A2 (en) 2008-03-20
SI2066340T1 (sl) 2013-11-29
EP2066340B1 (en) 2013-07-31
RU2425692C2 (ru) 2011-08-10
PT2066340E (pt) 2013-10-30
CL2007002621A1 (es) 2008-03-14
EP2377550B1 (en) 2015-03-04
TWI361077B (en) 2012-04-01
JP5643906B2 (ja) 2014-12-17
KR20090039840A (ko) 2009-04-22
ZA200902493B (en) 2010-03-31
JP5550341B2 (ja) 2014-07-16
CA2663166C (en) 2015-11-03
US8491915B2 (en) 2013-07-23
CN101516393A (zh) 2009-08-26
EP2066340A2 (en) 2009-06-10
DK2066340T3 (da) 2013-10-14
JP2010502238A (ja) 2010-01-28
UA98115C2 (ru) 2012-04-25
NZ574896A (en) 2011-11-25
NO339147B1 (no) 2016-11-14
MX2009001849A (es) 2009-03-02
PL2066340T3 (pl) 2013-12-31
HK1130202A1 (en) 2009-12-24
PL2377550T3 (pl) 2015-07-31
AR062758A1 (es) 2008-12-03
TW200820990A (en) 2008-05-16
EP2377550A1 (en) 2011-10-19
CA2663166A1 (en) 2008-03-20
AU2007297287A1 (en) 2008-03-20
ME00598B (me) 2011-12-20
BRPI0716548B1 (pt) 2020-10-06
BRPI0716548A2 (pt) 2013-09-24
CN101516393B (zh) 2014-05-14
RU2011115400A (ru) 2012-10-27
WO2008032158A3 (en) 2008-07-03
RS20090088A (en) 2010-06-30

Similar Documents

Publication Publication Date Title
DK2376015T3 (da) Pneumopedisk-ortodontisk instrument, system og fremgangsmåde.
NO20084751L (no) Akustisk flis
CY1116622T1 (el) Αντισωματα anti-cd22, τα ανοσοσυζευγματα τους και χρησεις αυτων
NO20074436L (no) Stigerørsfri modulær undervanns brønnintervensjon, fremgangsmåte og anordning
NO20092052L (no) Antistoffer og immunkonjugater, og anvendelser derav
DE602006005475D1 (de) Katheter
NL2003118A1 (nl) Alignment system, lithographic system and method.
NO20075471L (no) Betjening av en eller flere drivstoffautomater
ATE486297T1 (de) Mehrstufige schicht
BRPI0813914A2 (pt) Sistema, e, método.
BRPI0822078A2 (pt) Método, e, sistema.
DK1863526T3 (da) Levende, attenueret rotavirusvaccine til oral indgivelse
NL2001649A1 (nl) Non-bolt joint structure and method for producing non-bolt joint structure.
BRPI0716262B8 (pt) (heteroaril)-alquil-sulfiliminas n-substituídas, composição e método para controlar insetos
BRPI0820122A2 (pt) Método de otimização de produção de poços, sistema, e método.
NL1036277A1 (nl) Lithographic apparatus, stage system and stage control method.
NO20064034L (no) Makrolider og fremgangsmater for a fremstille disse
NO20073680L (no) Fremgangsmate for a analysere data som har felles og saerskilte egenskaper
BRPI0815834A2 (pt) Método, caixa automático, e, sistema.
IL193560A0 (en) Novel microorganism and method for producing dodecahydro-3a,6,6,9a-
NO20060976L (no) Vaksine
DK2224951T3 (da) Varmebehandlede bakteriner og emulsionsvacciner, der er fremstillet af sådanne varmebehandlede bakteriner
NO20090745L (no) Varmebehandlete bakteriner, og emulsjonsvaksiner fremstilt av slike varmebehandlete bakteriner
WO2009056281A3 (de) Medizinisches implantat
BRPI0821626A2 (pt) Conjunto colocado abaixo da água e método para produção de gás, ou gás e condesado/ óleo.

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ZOETIS P LLC, US

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ZOETIS SERVICES LLC, US

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ZOETIS SERVICES LLC, US